Cargando…
Predilection site and risk factor of second primary cancer: A pan-cancer analysis based on the SEER database
Autores principales: | Xiong, Shan, Liang, Hengrui, Liang, Peng, Cai, Xiuyu, Li, Caichen, Zhong, Ran, Li, Jianfu, Cheng, Bo, Zhu, Feng, Ou, Limin, Chen, Zisheng, Zhao, Yi, Deng, Hongsheng, Chen, Zhuxing, Liu, Zhichao, Xie, Zhanhong, Li, Feng, He, Jianxing, Liang, Wenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278722/ https://www.ncbi.nlm.nih.gov/pubmed/37101356 http://dx.doi.org/10.1097/CM9.0000000000002681 |
Ejemplares similares
-
Dynamic monitoring serum tumor markers to predict molecular features of EGFR‐mutated lung cancer during targeted therapy
por: Chen, Zhuxing, et al.
Publicado: (2022) -
Management for Residual Ground-Glass Opacity Lesions After Resection of Main Tumor in Multifocal Lung Cancer: A Case Report and Literature Review
por: Cheng, Bo, et al.
Publicado: (2021) -
An annual review of the remarkable advances in lung cancer clinical research in 2019
por: Cheng, Bo, et al.
Publicado: (2020) -
The association between CD8+ tumor-infiltrating lymphocytes and the clinical outcome of cancer immunotherapy: A systematic review and meta-analysis
por: Li, Feng, et al.
Publicado: (2021) -
Preoperative immunochemotherapy for locally advanced non-small cell lung cancer: an analysis of the clinical outcomes, optimal number of cycles, and peripheral immune markers
por: Deng, Hongsheng, et al.
Publicado: (2022)